{
  "metadata": {
    "version": "1.0",
    "created": "2025-11-26",
    "description": "Curated neuropsych drug seed list for Depression, Anxiety, ADHD",
    "total_drugs": 68,
    "tier_counts": {
      "gold": 42,
      "silver": 16,
      "bronze": 10
    }
  },
  "drugs": [
    {
      "name": "fluoxetine",
      "synonyms": ["Prozac", "Sarafem"],
      "class": "SSRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Anxiety", "OCD"],
      "notes": "First SSRI approved, extensive evidence base"
    },
    {
      "name": "sertraline",
      "synonyms": ["Zoloft"],
      "class": "SSRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Anxiety", "PTSD", "OCD"],
      "notes": "Most prescribed antidepressant"
    },
    {
      "name": "paroxetine",
      "synonyms": ["Paxil", "Seroxat"],
      "class": "SSRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Anxiety", "Panic Disorder"],
      "notes": "Strong anxiolytic properties"
    },
    {
      "name": "citalopram",
      "synonyms": ["Celexa"],
      "class": "SSRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "Most selective SSRI"
    },
    {
      "name": "escitalopram",
      "synonyms": ["Lexapro", "Cipralex"],
      "class": "SSRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Anxiety"],
      "notes": "S-enantiomer of citalopram, better tolerability"
    },
    {
      "name": "fluvoxamine",
      "synonyms": ["Luvox"],
      "class": "SSRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["OCD", "Anxiety"],
      "notes": "Sigma-1 agonist activity"
    },
    {
      "name": "venlafaxine",
      "synonyms": ["Effexor"],
      "class": "SNRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Anxiety", "Panic Disorder"],
      "notes": "First SNRI, dose-dependent NRI"
    },
    {
      "name": "duloxetine",
      "synonyms": ["Cymbalta"],
      "class": "SNRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Anxiety", "Neuropathic Pain"],
      "notes": "Balanced SERT/NET inhibition"
    },
    {
      "name": "desvenlafaxine",
      "synonyms": ["Pristiq"],
      "class": "SNRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "Active metabolite of venlafaxine"
    },
    {
      "name": "levomilnacipran",
      "synonyms": ["Fetzima"],
      "class": "SNRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "Higher NET selectivity"
    },
    {
      "name": "amitriptyline",
      "synonyms": ["Elavil"],
      "class": "TCA",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Neuropathic Pain", "Migraine Prophylaxis"],
      "notes": "Classic TCA, strong anticholinergic"
    },
    {
      "name": "nortriptyline",
      "synonyms": ["Pamelor"],
      "class": "TCA",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "Metabolite of amitriptyline, better tolerated"
    },
    {
      "name": "imipramine",
      "synonyms": ["Tofranil"],
      "class": "TCA",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Enuresis"],
      "notes": "First TCA, historical significance"
    },
    {
      "name": "clomipramine",
      "synonyms": ["Anafranil"],
      "class": "TCA",
      "tier": "gold",
      "status": "approved",
      "indications": ["OCD", "Depression"],
      "notes": "Most serotonergic TCA, gold standard for OCD"
    },
    {
      "name": "desipramine",
      "synonyms": ["Norpramin"],
      "class": "TCA",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "ADHD"],
      "notes": "Most noradrenergic TCA"
    },
    {
      "name": "phenelzine",
      "synonyms": ["Nardil"],
      "class": "MAOI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Anxiety"],
      "notes": "Irreversible MAOI, dietary restrictions required"
    },
    {
      "name": "tranylcypromine",
      "synonyms": ["Parnate"],
      "class": "MAOI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "Irreversible MAOI, amphetamine-like structure"
    },
    {
      "name": "selegiline",
      "synonyms": ["Emsam", "Eldepryl"],
      "class": "MAOI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Parkinson's"],
      "notes": "MAO-B selective at low doses, transdermal patch available"
    },
    {
      "name": "bupropion",
      "synonyms": ["Wellbutrin", "Zyban"],
      "class": "NDRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Smoking Cessation", "ADHD"],
      "notes": "Unique mechanism, activating profile, no sexual dysfunction"
    },
    {
      "name": "mirtazapine",
      "synonyms": ["Remeron"],
      "class": "NaSSA",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Insomnia", "Appetite Stimulation"],
      "notes": "Alpha-2 antagonist, 5-HT2/5-HT3 blocker, sedating"
    },
    {
      "name": "trazodone",
      "synonyms": ["Desyrel", "Oleptro"],
      "class": "SARI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression", "Insomnia"],
      "notes": "5-HT2A antagonist, commonly used for sleep"
    },
    {
      "name": "vilazodone",
      "synonyms": ["Viibryd"],
      "class": "SPARI",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "SSRI + 5-HT1A partial agonist"
    },
    {
      "name": "vortioxetine",
      "synonyms": ["Trintellix", "Brintellix"],
      "class": "Multimodal",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "Multiple serotonin receptor effects, pro-cognitive"
    },
    {
      "name": "alprazolam",
      "synonyms": ["Xanax"],
      "class": "Benzodiazepine",
      "tier": "gold",
      "status": "approved",
      "indications": ["Anxiety", "Panic Disorder"],
      "notes": "High potency, fast onset, abuse potential"
    },
    {
      "name": "lorazepam",
      "synonyms": ["Ativan"],
      "class": "Benzodiazepine",
      "tier": "gold",
      "status": "approved",
      "indications": ["Anxiety", "Status Epilepticus"],
      "notes": "Intermediate acting, no active metabolites"
    },
    {
      "name": "clonazepam",
      "synonyms": ["Klonopin"],
      "class": "Benzodiazepine",
      "tier": "gold",
      "status": "approved",
      "indications": ["Anxiety", "Panic Disorder", "Epilepsy"],
      "notes": "Long-acting, anticonvulsant properties"
    },
    {
      "name": "diazepam",
      "synonyms": ["Valium"],
      "class": "Benzodiazepine",
      "tier": "gold",
      "status": "approved",
      "indications": ["Anxiety", "Muscle Spasm", "Alcohol Withdrawal"],
      "notes": "Classic benzodiazepine, multiple active metabolites"
    },
    {
      "name": "buspirone",
      "synonyms": ["Buspar"],
      "class": "Azapirone",
      "tier": "gold",
      "status": "approved",
      "indications": ["Anxiety"],
      "notes": "5-HT1A partial agonist, non-sedating, no abuse potential"
    },
    {
      "name": "amphetamine",
      "synonyms": ["Adderall", "Evekeo"],
      "class": "Stimulant",
      "tier": "gold",
      "status": "approved",
      "indications": ["ADHD", "Narcolepsy"],
      "notes": "Mixed amphetamine salts, releases DA/NE"
    },
    {
      "name": "methylphenidate",
      "synonyms": ["Ritalin", "Concerta", "Focalin"],
      "class": "Stimulant",
      "tier": "gold",
      "status": "approved",
      "indications": ["ADHD", "Narcolepsy"],
      "notes": "DAT/NET blocker, first-line ADHD treatment"
    },
    {
      "name": "lisdexamfetamine",
      "synonyms": ["Vyvanse"],
      "class": "Stimulant",
      "tier": "gold",
      "status": "approved",
      "indications": ["ADHD", "Binge Eating Disorder"],
      "notes": "Prodrug of dextroamphetamine, smoother onset"
    },
    {
      "name": "atomoxetine",
      "synonyms": ["Strattera"],
      "class": "NRI",
      "tier": "gold",
      "status": "approved",
      "indications": ["ADHD"],
      "notes": "Non-stimulant, selective NET inhibitor"
    },
    {
      "name": "guanfacine",
      "synonyms": ["Intuniv", "Tenex"],
      "class": "Alpha-2 Agonist",
      "tier": "gold",
      "status": "approved",
      "indications": ["ADHD", "Hypertension"],
      "notes": "Alpha-2A selective, prefrontal cortex enhancement"
    },
    {
      "name": "clonidine",
      "synonyms": ["Kapvay", "Catapres"],
      "class": "Alpha-2 Agonist",
      "tier": "gold",
      "status": "approved",
      "indications": ["ADHD", "Hypertension", "Opioid Withdrawal"],
      "notes": "Non-selective alpha-2 agonist"
    },
    {
      "name": "aripiprazole",
      "synonyms": ["Abilify"],
      "class": "Atypical Antipsychotic",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression (adjunct)", "Bipolar", "Schizophrenia"],
      "notes": "D2 partial agonist, commonly used as adjunct"
    },
    {
      "name": "quetiapine",
      "synonyms": ["Seroquel"],
      "class": "Atypical Antipsychotic",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression (adjunct)", "Bipolar", "Schizophrenia"],
      "notes": "Low-dose for sleep/anxiety, FDA-approved adjunct"
    },
    {
      "name": "olanzapine",
      "synonyms": ["Zyprexa"],
      "class": "Atypical Antipsychotic",
      "tier": "gold",
      "status": "approved",
      "indications": ["Bipolar", "Schizophrenia", "Depression (with fluoxetine)"],
      "notes": "Combined with fluoxetine for TRD (Symbyax)"
    },
    {
      "name": "risperidone",
      "synonyms": ["Risperdal"],
      "class": "Atypical Antipsychotic",
      "tier": "gold",
      "status": "approved",
      "indications": ["Bipolar", "Schizophrenia", "Autism Irritability"],
      "notes": "D2/5-HT2A antagonist"
    },
    {
      "name": "brexpiprazole",
      "synonyms": ["Rexulti"],
      "class": "Atypical Antipsychotic",
      "tier": "gold",
      "status": "approved",
      "indications": ["Depression (adjunct)", "Schizophrenia"],
      "notes": "Next-gen aripiprazole, FDA-approved MDD adjunct"
    },
    {
      "name": "cariprazine",
      "synonyms": ["Vraylar"],
      "class": "Atypical Antipsychotic",
      "tier": "gold",
      "status": "approved",
      "indications": ["Bipolar Depression", "Schizophrenia"],
      "notes": "D3-preferring partial agonist"
    },
    {
      "name": "lithium",
      "synonyms": ["Lithobid", "Eskalith"],
      "class": "Mood Stabilizer",
      "tier": "gold",
      "status": "approved",
      "indications": ["Bipolar", "Depression (augmentation)"],
      "notes": "Gold standard mood stabilizer, anti-suicidal"
    },
    {
      "name": "lamotrigine",
      "synonyms": ["Lamictal"],
      "class": "Mood Stabilizer",
      "tier": "gold",
      "status": "approved",
      "indications": ["Bipolar Depression", "Epilepsy"],
      "notes": "Glutamate modulator, uniquely effective for bipolar depression"
    },
    {
      "name": "esketamine",
      "synonyms": ["Spravato"],
      "class": "NMDA Antagonist",
      "tier": "silver",
      "status": "approved",
      "indications": ["Treatment-Resistant Depression"],
      "notes": "Nasal spray, rapid onset, REMS program"
    },
    {
      "name": "zuranolone",
      "synonyms": ["Zurzuvae", "SAGE-217"],
      "class": "GABA-A PAM",
      "tier": "silver",
      "status": "approved",
      "indications": ["Postpartum Depression", "Depression"],
      "notes": "Oral neurosteroid, 14-day course, rapid response"
    },
    {
      "name": "brexanolone",
      "synonyms": ["Zulresso"],
      "class": "GABA-A PAM",
      "tier": "silver",
      "status": "approved",
      "indications": ["Postpartum Depression"],
      "notes": "IV infusion neurosteroid, hospital-administered"
    },
    {
      "name": "ganaxolone",
      "synonyms": ["Ztalmy"],
      "class": "GABA-A PAM",
      "tier": "silver",
      "status": "approved",
      "indications": ["Epilepsy"],
      "notes": "In trials for anxiety/depression, synthetic neurosteroid"
    },
    {
      "name": "psilocybin",
      "synonyms": [],
      "class": "Psychedelic",
      "tier": "silver",
      "status": "phase3",
      "indications": ["Treatment-Resistant Depression"],
      "notes": "Breakthrough therapy designation, COMPASS Pathways"
    },
    {
      "name": "MDMA",
      "synonyms": ["Midomafetamine"],
      "class": "Entactogen",
      "tier": "silver",
      "status": "phase3",
      "indications": ["PTSD"],
      "notes": "FDA rejected Aug 2024, Lykos resubmitting with new trials"
    },
    {
      "name": "AXS-05",
      "synonyms": ["dextromethorphan-bupropion", "Auvelity"],
      "class": "NMDA Modulator",
      "tier": "silver",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "First oral rapid-acting antidepressant"
    },
    {
      "name": "REL-1017",
      "synonyms": ["esmethadone"],
      "class": "NMDA Antagonist",
      "tier": "silver",
      "status": "phase3",
      "indications": ["Treatment-Resistant Depression"],
      "notes": "Non-opioid methadone enantiomer, Relmada"
    },
    {
      "name": "ulotaront",
      "synonyms": ["SEP-363856"],
      "class": "TAAR1 Agonist",
      "tier": "silver",
      "status": "phase3",
      "indications": ["Schizophrenia", "Depression"],
      "notes": "Novel mechanism, no D2 binding, Sumitomo/Otsuka"
    },
    {
      "name": "emraclidine",
      "synonyms": ["CVL-231"],
      "class": "M4 PAM",
      "tier": "silver",
      "status": "phase2",
      "indications": ["Schizophrenia"],
      "notes": "Cerevel, muscarinic approach to psychosis"
    },
    {
      "name": "KarXT",
      "synonyms": ["xanomeline-trospium", "Cobenfy"],
      "class": "M1/M4 Agonist",
      "tier": "silver",
      "status": "approved",
      "indications": ["Schizophrenia"],
      "notes": "First novel mechanism schizophrenia drug in 70 years, Karuna/BMS"
    },
    {
      "name": "gepirone",
      "synonyms": ["Exxua"],
      "class": "5-HT1A Agonist",
      "tier": "silver",
      "status": "approved",
      "indications": ["Depression"],
      "notes": "Selective 5-HT1A agonist, buspirone analog, Fabre-Kramer"
    },
    {
      "name": "capivasertib",
      "synonyms": [],
      "class": "AKT Inhibitor",
      "tier": "silver",
      "status": "phase2",
      "indications": ["Treatment-Resistant Depression"],
      "notes": "mTOR pathway modulator, repositioning from oncology"
    },
    {
      "name": "centanafadine",
      "synonyms": ["CTN-001"],
      "class": "TRI",
      "tier": "silver",
      "status": "phase3",
      "indications": ["ADHD"],
      "notes": "Triple reuptake inhibitor, Otsuka"
    },
    {
      "name": "viloxazine",
      "synonyms": ["Qelbree"],
      "class": "NRI",
      "tier": "silver",
      "status": "approved",
      "indications": ["ADHD"],
      "notes": "Non-stimulant, serotonin modulation, Supernus"
    },
    {
      "name": "solriamfetol",
      "synonyms": ["Sunosi"],
      "class": "DNRI",
      "tier": "silver",
      "status": "approved",
      "indications": ["Narcolepsy", "Sleep Apnea"],
      "notes": "Wakefulness agent, potential ADHD expansion"
    },
    {
      "name": "MIJ-821",
      "synonyms": [],
      "class": "NMDA NR2B Antagonist",
      "tier": "bronze",
      "status": "phase2",
      "indications": ["Treatment-Resistant Depression"],
      "notes": "Novartis, GluN2B-selective"
    },
    {
      "name": "BNC-210",
      "synonyms": [],
      "class": "Î±7 NAM",
      "tier": "bronze",
      "status": "phase2",
      "indications": ["PTSD", "Anxiety"],
      "notes": "Bionomics, nicotinic receptor modulator"
    },
    {
      "name": "NRX-101",
      "synonyms": [],
      "class": "NMDA Modulator",
      "tier": "bronze",
      "status": "phase3",
      "indications": ["Bipolar Depression", "Suicidal Ideation"],
      "notes": "d-cycloserine + lurasidone combination, NeuroRx"
    },
    {
      "name": "PCN-101",
      "synonyms": ["apimostinel"],
      "class": "NMDA Modulator",
      "tier": "bronze",
      "status": "phase2",
      "indications": ["Depression"],
      "notes": "NMDA positive modulator, Aptinyx spinoff"
    },
    {
      "name": "MM-120",
      "synonyms": ["LSD"],
      "class": "Psychedelic",
      "tier": "bronze",
      "status": "phase2",
      "indications": ["Anxiety"],
      "notes": "MindMed, optimized LSD for GAD"
    },
    {
      "name": "DMT",
      "synonyms": ["SPL-026"],
      "class": "Psychedelic",
      "tier": "bronze",
      "status": "phase2",
      "indications": ["Depression"],
      "notes": "Small Pharma (acquired), IV DMT-assisted therapy"
    },
    {
      "name": "danavorexton",
      "synonyms": [],
      "class": "Orexin Agonist",
      "tier": "bronze",
      "status": "phase2",
      "indications": ["Narcolepsy", "Depression"],
      "notes": "Takeda, orexin-2 selective agonist"
    },
    {
      "name": "TNX-102",
      "synonyms": [],
      "class": "Muscle Relaxant",
      "tier": "bronze",
      "status": "phase3",
      "indications": ["Fibromyalgia", "PTSD"],
      "notes": "Tonix, sublingual cyclobenzaprine"
    },
    {
      "name": "navacaprant",
      "synonyms": ["BTRX-335140"],
      "class": "KOR Antagonist",
      "tier": "bronze",
      "status": "phase2",
      "indications": ["Depression"],
      "notes": "BlackThorn, kappa opioid receptor antagonist"
    }
  ],
  "targets": [
    {
      "symbol": "SLC6A4",
      "name": "SERT (Serotonin Transporter)",
      "uniprot_id": "P31645",
      "pathway": "serotonin",
      "notes": "Primary target of SSRIs"
    },
    {
      "symbol": "HTR1A",
      "name": "5-HT1A Receptor",
      "uniprot_id": "P08908",
      "pathway": "serotonin",
      "notes": "Autoreceptor, anxiolytic target"
    },
    {
      "symbol": "HTR2A",
      "name": "5-HT2A Receptor",
      "uniprot_id": "P28223",
      "pathway": "serotonin",
      "notes": "Psychedelic target, blocked by atypicals"
    },
    {
      "symbol": "HTR2C",
      "name": "5-HT2C Receptor",
      "uniprot_id": "P28335",
      "pathway": "serotonin",
      "notes": "Weight/appetite regulation"
    },
    {
      "symbol": "HTR7",
      "name": "5-HT7 Receptor",
      "uniprot_id": "P34969",
      "pathway": "serotonin",
      "notes": "Circadian rhythm, cognition"
    },
    {
      "symbol": "SLC6A3",
      "name": "DAT (Dopamine Transporter)",
      "uniprot_id": "Q01959",
      "pathway": "dopamine",
      "notes": "Stimulant target"
    },
    {
      "symbol": "DRD1",
      "name": "D1 Dopamine Receptor",
      "uniprot_id": "P21728",
      "pathway": "dopamine",
      "notes": "Gs-coupled, reward/cognition"
    },
    {
      "symbol": "DRD2",
      "name": "D2 Dopamine Receptor",
      "uniprot_id": "P14416",
      "pathway": "dopamine",
      "notes": "Main antipsychotic target"
    },
    {
      "symbol": "DRD3",
      "name": "D3 Dopamine Receptor",
      "uniprot_id": "P35462",
      "pathway": "dopamine",
      "notes": "Limbic-selective"
    },
    {
      "symbol": "DRD4",
      "name": "D4 Dopamine Receptor",
      "uniprot_id": "P21917",
      "pathway": "dopamine",
      "notes": "ADHD candidate gene"
    },
    {
      "symbol": "SLC6A2",
      "name": "NET (Norepinephrine Transporter)",
      "uniprot_id": "P23975",
      "pathway": "norepinephrine",
      "notes": "SNRI/NRI target"
    },
    {
      "symbol": "ADRA2A",
      "name": "Alpha-2A Adrenergic Receptor",
      "uniprot_id": "P08913",
      "pathway": "norepinephrine",
      "notes": "Guanfacine target"
    },
    {
      "symbol": "GRIN1",
      "name": "NMDA Receptor NR1",
      "uniprot_id": "Q05586",
      "pathway": "glutamate",
      "notes": "Obligatory NMDA subunit"
    },
    {
      "symbol": "GRIN2A",
      "name": "NMDA Receptor NR2A",
      "uniprot_id": "Q12879",
      "pathway": "glutamate",
      "notes": "Adult synaptic NMDA"
    },
    {
      "symbol": "GRIN2B",
      "name": "NMDA Receptor NR2B",
      "uniprot_id": "Q13224",
      "pathway": "glutamate",
      "notes": "Ketamine binding site, TRD target"
    },
    {
      "symbol": "GABRA1",
      "name": "GABA-A Receptor Alpha-1",
      "uniprot_id": "P14867",
      "pathway": "GABA",
      "notes": "Sedation, amnesia"
    },
    {
      "symbol": "GABRA2",
      "name": "GABA-A Receptor Alpha-2",
      "uniprot_id": "P47869",
      "pathway": "GABA",
      "notes": "Anxiolytic without sedation"
    },
    {
      "symbol": "GABRA5",
      "name": "GABA-A Receptor Alpha-5",
      "uniprot_id": "P31644",
      "pathway": "GABA",
      "notes": "Cognition, inverse agonists procognitive"
    },
    {
      "symbol": "TAAR1",
      "name": "Trace Amine-Associated Receptor 1",
      "uniprot_id": "Q96RJ0",
      "pathway": "monoamine",
      "notes": "Novel schizophrenia/depression target"
    },
    {
      "symbol": "CHRM4",
      "name": "Muscarinic M4 Receptor",
      "uniprot_id": "P08173",
      "pathway": "cholinergic",
      "notes": "Schizophrenia target (KarXT, emraclidine)"
    },
    {
      "symbol": "OPRM1",
      "name": "Mu Opioid Receptor",
      "uniprot_id": "P35372",
      "pathway": "opioid",
      "notes": "Mood regulation, anhedonia"
    },
    {
      "symbol": "OPRD1",
      "name": "Delta Opioid Receptor",
      "uniprot_id": "P41143",
      "pathway": "opioid",
      "notes": "Antidepressant-like in animals"
    },
    {
      "symbol": "OPRK1",
      "name": "Kappa Opioid Receptor",
      "uniprot_id": "P41145",
      "pathway": "opioid",
      "notes": "Dysphoria, antagonists antidepressant"
    },
    {
      "symbol": "SIGMAR1",
      "name": "Sigma-1 Receptor",
      "uniprot_id": "Q99720",
      "pathway": "sigma",
      "notes": "Neuroprotection, cognition"
    },
    {
      "symbol": "BDNF",
      "name": "Brain-Derived Neurotrophic Factor",
      "uniprot_id": "P23560",
      "pathway": "neurotrophin",
      "notes": "Plasticity, downstream of antidepressants"
    },
    {
      "symbol": "NTRK2",
      "name": "TrkB Receptor",
      "uniprot_id": "Q16620",
      "pathway": "neurotrophin",
      "notes": "BDNF receptor, plasticity"
    }
  ]
}
